SERUM HORMONE LEVELS IN MEN WITH END STAGE RENAL-DISEASE

被引:13
作者
CARLSTROM, K
POUSETTE, A
STEGE, R
LINDHOLM, A
机构
[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT UROL,S-14186 HUDDINGE,SWEDEN
[3] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1990年 / 24卷 / 01期
关键词
Adrenal androgens; Cortisol; End stage renal disease; Estrogens; Steroid conjugates;
D O I
10.3109/00365599009180364
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum concentrations of testicular and adrenal androgens and androgen precursors, Cortisol, unconjugated (E1) and total estrone (tE1; >85% E1 sulfate). pituitary hormones, sex hormone binding globulin (SHBG) and albumin were measured in 14 male patients with nondiabetic end stage renal disease and in 28 age-matched healthy controls, The serum levels of the adrenal androgens 4-androstene 3,17-dione and dehydroepiandroster-one (DHA) were significantly lower and the levels of cortisol, LH, prolactin and tE1 significantly higher in the patients than in the controls. The ratios between E1 and tE1 and between DHA and DHA sulfate were strongly decreased in the patients, The findings are suggested to reflect different effects of the disease upon the metabolism of cortisol and of adrenal androgens and also the reduced or even absent urinary excretion. leading to a decreased metabolism of steroid conjugates. © 1990 Informa UK Ltd.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [31] MEASURING, MANAGING, AND IMPROVING THE QUALITY OF END-STAGE RENAL-DISEASE CARE
    LEVINSKY, NG
    MESLER, DE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (02) : 235 - 246
  • [32] SCREENING OF INTESTINAL IRON-ABSORPTION IN END-STAGE RENAL-DISEASE
    SELMAIER, A
    SAMTLEBEN, W
    LORENZ, B
    GURLAND, HJ
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1994, 23 (02) : 77 - 83
  • [33] RACE, SOCIOECONOMIC-STATUS, AND THE DEVELOPMENT OF END-STAGE RENAL-DISEASE
    BYRNE, C
    NEDELMAN, J
    LUKE, RG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (01) : 16 - 22
  • [34] CLOTTING BY HEPARIN OF HEMOACCESS FOR HEMODIALYSIS IN AN END-STAGE RENAL-DISEASE PATIENT
    PHAM, PT
    MILLER, JM
    DEMETRION, G
    LEW, SQ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) : 642 - 647
  • [35] THE FAMILIAL RISK OF END-STAGE RENAL-DISEASE IN AFRICAN-AMERICANS
    FREEDMAN, BI
    SPRAY, BJ
    TUTTLE, AB
    BUCKALEW, VM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 387 - 393
  • [37] RACIAL ORIGIN AND PRIMARY RENAL DIAGNOSIS IN 771 PATIENTS WITH END-STAGE RENAL-DISEASE
    PAZIANAS, M
    EASTWOOD, JB
    MACRAE, KD
    PHILLIPS, ME
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (12) : 931 - 935
  • [38] HYPERTENSION-RELATED RENAL INJURY - A MAJOR CONTRIBUTOR TO END-STAGE RENAL-DISEASE
    WALKER, WG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) : 164 - 173
  • [39] GEOGRAPHIC-VARIATION IN THE INCIDENCE OF TREATED END-STAGE RENAL-DISEASE
    FOXMAN, B
    MOULTON, LH
    WOLFE, RA
    GUIRE, KE
    PORT, FK
    HAWTHORNE, VM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1991, 2 (06): : 1144 - 1152
  • [40] BIOCHEMICAL-CHARACTERIZATION OF SERUM AND URINARY BETA-2 MICROGLOBULIN IN END-STAGE RENAL-DISEASE PATIENTS
    ARGILES, A
    DERANCOURT, J
    JAUREGUIADELL, J
    MION, C
    DEMAILLE, JG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (11) : 1106 - 1110